Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis.

Reid, Pankti; Danahey, Keith; Lopez Velazquez, Marco; Ratain, Mark J; O'Donnell, Peter H

Reid, Pankti; Danahey, Keith; Lopez Velazquez, Marco; Ratain, Mark J; O'Donnell, Peter H.

Afiliación

Reid P; Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, and Section of Rheumatology, Department of Medicine, University of Chicago, IL, USA. pankti.reid@uchospitals.edu.
Danahey K; Center for Research Informatics, and Center for Personalized Therapeutics, University of Chicago, IL, USA.
Lopez Velazquez M; Section of Rheumatology, Department of Medicine, University of Chicago, IL, USA.
Ratain MJ; Committee on Clinical Pharmacology and Pharmacogenomics, Center for Personalized Therapeutics, and Department of Medicine, University of Chicago, IL, USA.
O'Donnell PH; Committee on Clinical Pharmacology and Pharmacogenomics, Center for Personalized Therapeutics, and Department of Medicine, University of Chicago, IL, USA.

Clin Exp Rheumatol ; 39(6): 1385-1393, 2021.

Article en En | MEDLINE | ID: mdl-33506753

Asunto(s)

Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos; Reumatología; Adulto; Prescripciones de Medicamentos; Humanos; Farmacogenética; Pruebas de Farmacogenómica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Reumatología / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Clin Exp Rheumatol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google